Metformin in Safety and Efficacy in Gouty Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 20, 2025

Primary Completion Date

November 20, 2026

Study Completion Date

November 20, 2026

Conditions
Gout
Interventions
OTHER

placebo

Placebo will have the same look of metformin

DRUG

Metformin

Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients

Trial Locations (1)

31527

RECRUITING

Tanta Unuversity, Tanta

All Listed Sponsors
lead

Mostafa Bahaa

OTHER